Thrombin-activatable fibrinolysis inhibitor aka procarboxypeptidase U

Bron
Haemostasis and thrombosis: basic principles and clinical practice / Colman [edit.]-p. 381-394
Auteur(s)

Fast kinetic assay for the determination of procarboxypeptidase U (TAFI) in human plasma

Bron
Journal of thrombosis and haemostasis - ISSN 1538-7933-3:10 (2005) p. 2353-2355
Auteur(s)

Carboxypeptidase U (TAFIa): a metallocarboxypeptidase with a distinct role in haemostasis and a possible risk factor for thrombotic disease

Bron
Thrombosis and haemostasis : international journal for vascular biology and medicine - ISSN 0340-6245-94:3 (2005) p. 471-487

HMR 3339, a novel selective estrogen receptor modulator, reduces concentrations of procarboxypeptidase U, an inhibitor of fibrinolysis: a randomized, placebo-controlled study in postmenopausal women

Bron
Journal of thrombosis and haemostasis - ISSN 1538-7933-3:5 (2005) p. 1090-1092
Auteur(s)
    T.E. Vogelvang, Judith Leurs, V. Mijatovic, Johan Willemse, M.J. van der Mooren

Different effects of low-dose transdermal and oral oestrogen therapy on procarboxypeptidase U, an inhibitor of fibrinolysis, in healthy postmenopausal women: a randomised, placebo-controlled study

Bron
Thrombosis and haemostasis : international journal for vascular biology and medicine - ISSN 0340-6245-93:3 (2005) p. 620-622
Auteur(s)